Multilocus sequence types associated with neonatal group B streptococcal sepsis and meningitis in Canada.
about
Human Streptococcus agalactiae strains in aquatic mammals and fishProteomic biomarkers associated with Streptococcus agalactiae invasive genogroupsEmerging Trends in the Epidemiology of Invasive Group B Streptococcal Disease in England and Wales, 1991-2010Association of Group B Streptococcus colonization and bovine exposure: a prospective cross-sectional cohort studyGenetic diversity and antimicrobial resistance in Streptococcus agalactiae strains recovered from female carriers in the Bucharest area.Molecular characterization and prophage DNA contents of Streptococcus agalactiae strains isolated from adult skin and osteoarticular infections.Pilus distribution among lineages of group b streptococcus: an evolutionary and clinical perspectiveTwo-component system RgfA/C activates the fbsB gene encoding major fibrinogen-binding protein in highly virulent CC17 clone group B Streptococcus.Contribution of pilus type 2b to invasive disease caused by a Streptococcus agalactiae ST-17 strain.Diversity of prophage DNA regions of Streptococcus agalactiae clonal lineages from adults and neonates with invasive infectious disease.Clonal analysis of colonizing group B Streptococcus, serotype IV, an emerging pathogen in the United States.The surface protein HvgA mediates group B streptococcus hypervirulence and meningeal tropism in neonatesInteraction of Streptococcus agalactiae and Cellular Innate Immunity in Colonization and DiseaseAssociation and virulence gene expression vary among serotype III group B streptococcus isolates following exposure to decidual and lung epithelial cells.Transcriptomic and genomic evidence for Streptococcus agalactiae adaptation to the bovine environment.Serotypes, antibiotic susceptibilities, and multi-locus sequence type profiles of Streptococcus agalactiae isolates circulating in Beijing, China.Host cytosolic phospholipase A₂α contributes to group B Streptococcus penetration of the blood-brain barrier.Genomic comparison of virulent and non-virulent Streptococcus agalactiae in fish.Molecular epidemiology and distribution of serotypes, genotypes, and antibiotic resistance genes of Streptococcus agalactiae clinical isolates from Guelma, Algeria and Marseille, France.The application of multiplex PCR to detect seven different DNA targets in group B streptococciStreptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline.L-ficolin and capsular polysaccharide-specific IgG in cord serum contribute synergistically to opsonophagocytic killing of serotype III and V group B streptococci.Association between genotypic diversity and biofilm production in group B StreptococcusWhole-Genome Comparison Uncovers Genomic Mutations between Group B Streptococci Sampled from Infected Newborns and Their Mothers.Estimating the burden of invasive Group B Streptococcal disease in young infants in southern mainland China: an observational studyStreptococcus agalactiae Causing Neonatal Infections in Portugal (2005-2015): Diversification and Emergence of a CC17/PI-2b Multidrug Resistant Sublineage.Whole-genome shotgun sequencing of a colonizing multilocus sequence type 17 Streptococcus agalactiae strainHigh prevalence of fluoroquinolone-resistant group B streptococci among clinical isolates in China and predominance of sequence type 19 with serotype III.Epidemiology of Invasive Group B Streptococcal Disease in Alberta, Canada, from 2003 to 2013Serotype IV Streptococcus agalactiae ST-452 has arisen from large genomic recombination events between CC23 and the hypervirulent CC17 lineages.Genomic Analysis Reveals Multi-Drug Resistance Clusters in Group B Streptococcus CC17 Hypervirulent Isolates Causing Neonatal Invasive Disease in Southern Mainland China.Molecular characterization and lytic activities of Streptococcus agalactiae bacteriophages and determination of lysogenic-strain features.Selection, recombination, and virulence gene diversity among group B streptococcal genotypes.Changing Epidemiology of Group B Streptococcus Susceptibility to Fluoroquinolones and Aminoglycosides in France.Streptococcus agalactiae Serotype IV in Humans and Cattle, Northern Europe(1).Contribution of the RgfD Quorum Sensing Peptide to rgf Regulation and Host Cell Association in Group B Streptococcus.Acidic pH strongly enhances in vitro biofilm formation by a subset of hypervirulent ST-17 Streptococcus agalactiae strains.Characterization of invasive group B streptococcus strains from the greater Toronto area, Canada.Group B streptococcal disease and genotypes in Australian infants.Cross-resistance to lincosamides, streptogramins A and pleuromutilins in Streptococcus agalactiae isolates from the USA.
P2860
Q28285771-FB1FE4B7-5352-4E4B-B3BC-C45CC064CE97Q28485254-D54F73BF-AD43-40EB-8949-0C27031ABC21Q30040402-1F9FFF68-42D7-495D-9E2A-E7D665B1B067Q30976919-63EEA665-BAFB-4E6F-906B-335E865E9AC1Q33587116-FD8BDBAF-BC90-46E9-9FDA-B6FA6C1AC37FQ33769683-D6D44314-2004-4D35-BD5B-5E94F75B661FQ33820394-D8D0EA6F-8395-44F3-BA55-654D2D2B33E3Q33822141-3DBFB548-CD88-4CC7-AD6A-27CF5D1FA1C5Q33868597-BECC8FFE-8E80-4AF5-8002-17CD09881C5CQ33919763-553E9E25-EBFE-4DF1-A111-BE39F7B826CDQ34120642-CE6B77FD-5FFB-454E-BCE3-1884A91F9C62Q34243438-AB163E2D-F905-45C7-861B-3B6C1D17BA6BQ34419556-2D31A024-110D-4AAF-88F2-4A520565538BQ34596103-E6911B77-B675-4362-AB63-F5A6957FC88DQ35076247-B04A0CFF-D2C3-4652-A48C-7D854332D59EQ35188390-20676470-B6C8-4576-B050-27CC17DA7C31Q35273062-7F514903-9B7B-41D2-B24B-E11DBBFD537FQ35423260-83C7DD73-7FD2-4CAC-A44C-1D0D0E9B0A46Q35790825-C8B32835-59D1-4EB5-8C28-FC83B4D7D0C6Q35937146-7BBE998F-E716-4CFC-8FD1-8CCD02FC9D81Q35961823-C28BCF9E-4A48-4FE1-B07E-7A786584A32DQ36018153-6B9A8205-3674-4647-9437-DE6FB432F59BQ36024474-EDC2D8C9-2AF5-4C52-86D1-CB5A4A536851Q36070056-AD3A5D6A-7763-40F3-BAC4-3DDA67D2BB3CQ36183228-98955557-A787-4ED1-9B6F-6930F918ABC9Q36344089-482A03C1-9E79-43E5-AAFF-76CEDFBBB764Q36362720-C4434BC7-0CC2-454C-9C40-4907D4C5469FQ36667222-E0736BB9-BDD4-4943-A21A-7E267EB3DB36Q37040500-86F94173-B47B-423A-8935-0FA59D3B3310Q37093287-6EFE6305-659D-445B-924D-2CA554662E10Q37172465-350D5690-78FD-4F6B-98D2-F6653F0A0C0BQ37274986-43B608ED-4EE5-45C5-B182-252318C879C2Q37302049-CDEE7F34-3CE8-4AF8-B393-71921FF15BB9Q37428706-3A21CFDD-46AC-4D01-AB1D-EB6350A75054Q37535754-EB38B801-6929-4E11-AA5F-5099DBD3D11BQ37628267-7A6D0B9C-174B-4802-8462-F6E29E21E3D1Q37712890-ABD704C8-3F3C-4F17-B4E4-A7DC5B31A3C7Q37713818-2C3510FF-2B3F-41D1-8203-8D249C03BD23Q38345971-54F6653C-7836-4D2E-A969-3289404A1B21Q38883719-879C866E-A7D1-4558-A250-A2E4AF9676E9
P2860
Multilocus sequence types associated with neonatal group B streptococcal sepsis and meningitis in Canada.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Multilocus sequence types asso ...... psis and meningitis in Canada.
@en
Multilocus sequence types asso ...... psis and meningitis in Canada.
@nl
type
label
Multilocus sequence types asso ...... psis and meningitis in Canada.
@en
Multilocus sequence types asso ...... psis and meningitis in Canada.
@nl
prefLabel
Multilocus sequence types asso ...... psis and meningitis in Canada.
@en
Multilocus sequence types asso ...... psis and meningitis in Canada.
@nl
P2093
P2860
P921
P356
P1476
Multilocus sequence types asso ...... psis and meningitis in Canada.
@en
P2093
A Cody Springman
Erica Lehotzky
H Dele Davies
Maggi A Lewis
Thomas S Whittam
P2860
P304
P356
10.1128/JCM.01424-08
P407
P577
2009-01-21T00:00:00Z